Neuroendocrine Tumor Grant Opportunities
The Neuroendocrine Tumor Research Foundation (NETRF) is the leading non-profit organization supporting basic, translational and clinical NET research. Our mission is to accelerate scientific discovery that will help create new and more effective therapies for NETs.
Our grants range from $100,000 to $1.2 million for up to four years. We support scientists who conduct highly innovative research, whose work will help provide insight into the causes of NETs and/or lead to improved treatments for patients.
NETRF’s grant process is rigorous and competitive. Requests for funding must be aligned with a specific research award.
Applicants can apply to more than one award but can only submit one application per award. A NETRF Awardee can only hold one NETRF-sponsored award at any given time. For more details please see the “Award Program” document on proposalCENTRAL and the FAQs.
*Please note, the 2022 application portal has been closed and no more applications will be accepted.
Read the NETRF 2022 Award Program Guidelines
The NETRF employs a 2-step grant process:
1. Letters of Intent (LOI)
Grant opportunities will be open in January 2022. Interested applicants must submit a letter of intent (LOI) online via proposalCENTRAL that is due March 2022. Learn more about NETRF award criteria. LOIs sent directly to NETRF will not be considered.
2. Full Applications
A small number of investigators who submitted an LOI will be invited to submit a Full Proposal via proposalCENTRAL. Both the LOI and Full Proposal are reviewed by NETRF’s Board of Scientific Advisors and external expert reviewers. The most meritorious applications are recommended to NETRF’s Board of Directors for funding.
NETRF will notify applicants of grant decisions in late 2022 and offer feedback to those applicants whose grants are not funded. Applicants whose projects are approved for funding receive an award letter outlining the next steps
Read our Frequently Asked Questions
Recruiting new investigators to research NETs.